I seminari di Mogliano Veneto – VI Edizione

Reflections and Proposals for Sharing the Governance Tools of the Regional Pharmaceutical Assistance.

Type 2 diabetes mellitus (T2DM) is the most common form of diabetes mellitus, accounting for 90-95% of all cases. This pathology is significantly associated with

Myasthenia Graves and Neuromyelitis Optica are two rare pathologies. Myasthenia gravis (MG) is a rare autoimmune disease of the neuromuscular junctions, clinically heterogeneous, affecting both

The second seminar “Use of new (and old) antibiotics: a pragmatic proposal for place in therapy in critically ill patients” represents the closing appointment of

The recent pandemic has highlighted the negative effects of health care expenditure containment actions and the not always efficient allocation of resources allocated to public

This project, realized thanks to the unconditional sponsorship of Janssen, aims to support in a practical way the development process of mutational oncology and the

In the recent period, an irreversible trend has emerged, shared by all (decision-makers and health professionals) towards the “strengthening of the territory”, to provide it

In the recent period, an irreversible trend has emerged, shared by all (decision-makers and health professionals) towards the “strengthening of the territory”, to provide it

In the recent period, an irreversible trend has emerged, shared by all (decision-makers and health professionals) towards the “strengthening of the territory”, to provide it

The scientific community has long expressed the need for new antibiotic drugs to deal with infections by Multi-Drug Resistant (MDR) pathogens, and at the same

The fourth edition of the Mogliano Seminar intends to address two relevant aspects of the drug scenario. On the one hand, the prospects for the

Expert Panels: Alberto Bortolami Americo Cicchetti Giuseppe Curigliano Raimondo Di Liello Matteo Fassan Paolo Marchetti Giovanni Pappagallo Francesco Perrone

Expert Panels: Alberto Bortolami Americo Cicchetti Giuseppe Curigliano Raimondo Di Liello Matteo Fassan Paolo Marchetti Giovanni Pappagallo Francesco Perrone

Expert Panels: Paolo Bruzzi, Independent Advisor in Healthcare Claudio Jommi, CERGAS Bocconi University Umberto Malapelle, University of Naples Federico II Nicola Normanno, National Cancer Institute

The COVID-19 epidemic, with the consequent reorganization of hospital assistance aimed at managing new health needs and mitigating the fear of contagion of cancer patients,

Based on the experience conducted in the “Seminar on early access in oncology” (28 and 29 June 2018) – and the subsequent publication of the

In a new and dramatic condition such as the one we are experiencing: an unstoppable tsunami of uncertainties, fears, good and even false discoveries and

The optimal management of cardiovascular risk is a challenge that has been renewed over the years, due to the incessant advancement of knowledge and the

It is well known that Research is an engine of cultural, technological and economic development that is fundamental in the life of a country, whose

The system for accessing medicines to the National Health Service (SSN) has undoubted advantages, including the presence – at least formally – of a multi-criteria

In oncology, especially in the case of pathologies with limited therapeutic alternatives, drugs are increasingly approved on the basis of potentially relevant but early evidence,

The 2003 Group was set up to promote scientific research in Italy in all locations, in both the academic and industrial fields. With the series